Summary
In Zucker fa/fa rats with genetic obesity have been generally recognized to have symptoms such as hyperphagia, hyperlipemia, and hyperinsulinemia (1-3). In addition, there have been recent reports that Zucker fa/fa rats have C cell hyperplasia in the thyroid gland (4) and higher fasting plasma calcitonin and calcium levels (5). These observations suggest that there may be some alterations of mineral and vitamin D metabolism in hyperinsulinemic obese rats. In the present study, therefore, we have measured circulating levels of calcium and vitamin D metabolites in Zucker fa/fa rats. 
RESULTS
Body weight, fasting blood glucose and plasma insulin (Table 2) The rate of body weight increase was markedly higher in fa/fa rats than in their Calcium and vitamin D metabolites (Fig. 1 ) Plasma calcium levels in the fa/fa rats were significantly higher than in their lean littermates (p<0. (9) have recently observed that both plasma calcium and calcitonin levels are high in young (10 weeks of age) fa/fa obese rats . In the present study, we also found elevated calcium concentrations in rats with hyperinsulinemia aged 12-13 weeks. To the contrary, in experimental hypoinsulinemic diabetic rats , hypocalcemia has been reported (8) which may be caused by a negative calcium balance resulting from intestinal calcium malabsorption , hypercalciuria, and in creased fecal calcium excretion (10-13). Since renal 25(OH)D-la-hydroxylase ac tivity has been reported to be reduced in diabetic rats and reversed by insulin (14) , the activity of 1 a-hydroxylase seems to be increased in the hyperinsulinemic state . Accordingly, the observed hypercalcemia in fa/fa rats might be thought to be due to the increased intestinal calcium absorption and calcium mobilization from bone found with high plasma 1,25(OH)2D levels . However, in the present study, circulating 1,25(OH)2D was not elevated and the ratio of 1 ,25(OH)2D to 25(OH)D was not increased in fa/fa rats compared to their lean littermates . Hyperinsulinemia with obesity, therefore, may not produce the accelerated conversion into 1,25(OH)2D from 25(OH)D found in the present study . Calium-regulating hor mones other than this active vitamin D metabolite , such as parathyroid hor mone or calcitonin, could be involved in the hypercalcemia in these rats . Recent reports (4, 5, 9) have shown, however, that there are high plasma calcitonin levels and thyroid C cell hyperplasia under the condition of hypercalcemia in fa/fa rats . It seems likely, therefore, that calcitonin is not responsible for the hypercalcemia , and that C cell hyperplasia might be a secondary phenomenon , possibly to compensate for the elevated plasma calcium levels in these rats . Furthermore, fa/fa rats and lean littermates have been observed to show similar levels of plasma parathyroid hormone as measured by radioimmunoassay in which the antiserum used re cognized primarily the C-terminal region (5) . Therefore, at present , there seems to be no direct evidence that parathyroid hormone is related to the high plasma calcium levels in fa/fa rats. However, measurement by antiserum against the N terminal region of parathyroid hormone should be considered . It is possible, accordingly, that the increased calcium intake stemming from hyperphagia might be important in the positive calcium balance. Another possibility regarding the unchanged ratio of 1,25(OH)2D to 25(OH)D is that the conversion from 1,25(OH)2D into further metabolites or lactone bodies might be accelerated , resulting in normal plasma 1,25(OH)2D levels even if the production of 1 ,25(OH)2D is increased in the hyperinsulinemic state. Further studies are needed to clarify the details of mineral and vitamin D metabolism in genetic obesity .
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